Head of FDA's Device Division Resigns

WASHINGTON (Reuters) - The head of the U.S. Food and Drug Administration's device center stepped down on Tuesday, a move that follows a raft of scandals over safety recalls, concerns over the agency's device approval process and other controversial issues. Daniel Schultz, who served at the agency's Center for Devices and Radiological Health for 15 years, resigned after reaching an agreement with FDA Commissioner Margaret Hamburg "that my stepping down at this time would be in the best interest of the center and the agency."

BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section

---

Add this page to your favorite Social Bookmarking websites